| Literature DB >> 22467524 |
İlgar Kerimov1, Gülgün Ayhan-Kilcigil, Elçin Deniz Özdamar, Benay Can-Eke, Tülay Çoban, Süheyla Özbey, Canan Kazak.
Abstract
In this study, two new series of 2-amino-1,3,4-oxadiazoles and 5-aryl-1,3,4-oxadiazoles carrying a benzimidazole moiety were synthesized. The antioxidant properties of these compounds were investigated in vitro by the determination of the microsomal NADPH-dependent inhibition of lipid peroxidation levels (LP), the microsomal ethoxyresorufin O-deethylase activity (EROD), and DPPH radical scavenger effects. Among the tested compounds, 2-[(2-(4-chlorophenyl)-1H-benzo[d]imidazole-1-yl)methyl]-5-(4-fluorophenyl)-1,3,4-oxadiazole (9) was found to be the most active compound in all three in vitro systems.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22467524 DOI: 10.1002/ardp.201100440
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751